Bottom line
What does LFSC hold?
LFSC held 40 positions as of May 31, 2026. Its largest holding is Travere Therapeutics Inc at 7.67% of the fund, and the top 10 positions add up to 54.7%. By asset type it is 100% stocks.
Updated Jul 28, 2026
LFSC top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Travere Therapeutics Inc TVTX | Stocks | 7.67% | $8.1M |
| 2 | Cogent Biosciences Inc COGT | Stocks | 7.53% | $7.9M |
| 3 | LivaNova PLC LIVN | Stocks | 7.11% | $7.5M |
| 4 | Spyre Therapeutics Inc SYRE | Stocks | 6.41% | $6.7M |
| 5 | Guardant Health Inc GH | Stocks | 5.52% | $5.8M |
| 6 | Mirum Pharmaceuticals Inc MIRM | Stocks | 4.92% | $5.2M |
| 7 | Corcept Therapeutics Inc CORT | Stocks | 4.79% | $5.0M |
| 8 | United Therapeutics Corp UTHR | Stocks | 4.16% | $4.4M |
| 9 | VeraDermics Inc MANE | Stocks | 3.42% | $3.6M |
| 10 | Savara Inc SVRA | Stocks | 3.22% | $3.4M |
| 11 | Cytokinetics Inc CYTK | Stocks | 3.16% | $3.3M |
| 12 | Nektar Therapeutics NKTR | Stocks | 3.14% | $3.3M |
| 13 | Trevi Therapeutics Inc TRVI | Stocks | 3.12% | $3.3M |
| 14 | Dianthus Therapeutics Inc DNTH | Stocks | 3.09% | $3.2M |
| 15 | Axsome Therapeutics Inc AXSM | Stocks | 2.84% | $3.0M |
| 16 | Billiontoone Inc BLLN | Stocks | 2.73% | $2.9M |
| 17 | TransMedics Group Inc TMDX | Stocks | 2.68% | $2.8M |
| 18 | Viridian Therapeutics Inc VRDN | Stocks | 2.24% | $2.3M |
| 19 | ICU Medical Inc ICUI | Stocks | 2.09% | $2.2M |
| 20 | Corvus Pharmaceuticals Inc CRVS | Stocks | 1.95% | $2.1M |
| 21 | Palvella Therapeutics Inc PVLA | Stocks | 1.95% | $2.0M |
| 22 | Ceribell Inc CBLL | Stocks | 1.55% | $1.6M |
| 23 | Globus Medical Inc GMED | Stocks | 1.27% | $1.3M |
| 24 | Xeris Biopharma Holdings Inc XERS | Stocks | 1.22% | $1.3M |
| 25 | Bridgebio Pharma Inc BBIO | Stocks | 1.17% | $1.2M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 28, 2026